Based on ACR tips, allopurinol is strongly advised as a primary-line urate-reducing medication. Genetic screening is suggested (for just a variant called HLA B*5801) prior to starting allopurinol because the carriers of the gene are at an increased risk of the intense allergic reaction. Editor&rs